MedicaidCoverageMedium impact
Amtagvi (lifileucel) - MEDICAID - VIRGINIA (Revised)
Humana·VA · Oncology·Medicaid
Effective date
Jul 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicaid in Virginia now covers Amtagvi (lifileucel), a new immunotherapy for advanced melanoma, requiring medical director review and referral to Corporate Transplant Department. This is a specialized treatment for patients who failed previous therapies including PD-1 inhibitors and BRAF inhibitors.
Action Required
By July 1, 2025: Billing team must refer all Amtagvi (lifileucel) requests to Corporate Transplant Department at 1-866-421-5663 or transplant@humana.com. Update encounter forms to flag metastatic melanoma patients for medical director review. Use appropriate HCPCS codes C9399, J3490, or J3590 and ICD-10-PCS codes XW033L7 or XW043L7 for billing.